Business Case Studies, Corporate Strategy Case Study, Novartis, generic business

print page
Tell A Friend
Bookmark
 

Case Categories

Corporate Strategy Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novartis: Consolidation in Generics

Publication Year : 2005

Authors: Supratim Majumdar, Abhisekh Roy Chowdhury, Tirthankar Ray

Industry: Health Care

Region:Switzerland

Case Code: COS0076K

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
The case discusses the mega acquisition of two big generic pharmaceutical companies, Hexal AG of Germany and Eon Labs of the United States (US), by the world’s second largest generic pharmaceutical company - Swiss based Novartis (Sandoz, the generic business division of Novartis). The acquisitions created the largest generic pharmaceutical company in the world, in terms of revenue. The case provides a detailed note on the global generic pharmaceutical industry, with a focus on its recent trends. After giving a brief note on Sandoz and the two acquired companies, the case discusses the rationale behind the acquisition and the benefits, which Novartis expected from it. It also explains the acquisition deal in detail and finally, discusses the possible challenges, which Novartis could face in the near future.

Pedagogical Objectives:

  • To discuss the global Pharma industry
  • To understand the reasons for growth of Generics
  • To discuss about the acquisitions and the expected synergies
  • To debate on the challenges that Novartis could face in the generic business.

Keywords : Mergers,Acquisitions,Alliances Case Study;Novartis; Sandoz; Hexal AG; Eon Labs; Pharmaceutical (pharma) industry; Generic drugs; Patented drugs; Acquisition; Intellectual property rights; Blockbuster drug; Big pharma; Cost competitiveness; Extended product portfolio; Vertical integration; Daniel Vasella

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • David ConklinDavid Conklin

    David Conklin, is a professor at the Richard Ivey School of Business
    Speaks on Government and Business
  • Lord Meghnad DesaiLord Meghnad Desai

    Lord Meghnad Desai, is an Indian-born British economist and Labor politician
    Speaks on Government and Business
  • Vijay GovindarajanVijay Govindarajan

    Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
    Speaks on Reverse Innovation
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-500 082, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap